Literature DB >> 21841338

Atrial right-to-left shunt without pulmonary hypertension in a patient with biventricular non-compaction cardiomyopathy accompanied by ventricular and atrial septal defects.

Hirokazu Sakan1, Satoshi Okayama, Shiro Uemura, Satoshi Somekawa, Ken-ichi Ishigami, Yukiji Takeda, Hiroyuki Kawata, Manabu Horii, Shinichi Fujimoto, Yoshihiko Saito.   

Abstract

Echocardiography and magnetic resonance imaging revealed biventricular non-compaction cardiomyopathy with ventricular (VSD) and atrial (ASD) septal defects in an unconscious, 23-year-old hypoxemic man. Doppler echocardiography showed a left-to-right shunt across the VSD and a right-to-left shunt across the ASD. Cardiac catheterization revealed elevated right atrial pressure, although pulmonary pressure was normal. We considered that the atrial right-to-left shunt had induced the hypoxemia, which was related mainly to right ventricular dysfunction in this biventricular non-compaction cardiomyopathy, but it was not related to pulmonary hypertension.

Entities:  

Mesh:

Year:  2011        PMID: 21841338     DOI: 10.2169/internalmedicine.50.5290

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Stepwise Progression of Right-to-Left Atrial Shunting through a Combination of Patent Foramen Ovale and Tricuspid Regurgitation.

Authors:  Evan P Kransdorf; Lisa N Kransdorf; F David Fortuin; John P Sweeney; Susan Wilansky
Journal:  Tex Heart Inst J       Date:  2016-04-01

2.  Myocardial infarction in a patient with left ventricular noncompaction: a case report.

Authors:  Mehrnoush Toufan; Roya Shahvalizadeh; Majid Khalili
Journal:  Int J Gen Med       Date:  2012-08-06

3.  Left ventricular hypertrabeculation/noncompaction with epilepsy, other heart defects, minor facial anomalies and new copy number variants.

Authors:  Bert Nagel; Ursula Gruber-Sedlmayr; Sabine Uhrig; Claudia Stöllberger; Eva Klopocki; Josef Finsterer
Journal:  BMC Med Genet       Date:  2012-07-25       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.